Clinical trial
A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In…
NCT00165802 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00165802 |
|---|---|
| Title | A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid Tumors |
| Official title | A Phase I Open Label Study of E7974 Administered on Day 1 of a 21-Day Cycle In Patients With Advanced Solid Tumors |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer, Malignant Tumors |
| Intervention type | Drug |
| Interventions | E7974 |
| Enrollment | 40 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Jan 1, 2009 |
| First posted | Sep 14, 2005 |
| Last update posted | May 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: